Search hospitals > Pennsylvania > Pittsburgh

Magee Women's Hospital of UPMC

Claim this profile
Pittsburgh, Pennsylvania 15213
Global Leader in Breast Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Ovarian Cancer
Conducts research for Breast cancer
Conducts research for Cervical Adenocarcinoma
403 reported clinical trials
44 medical researchers
Photo of Magee Women's Hospital of UPMC in PittsburghPhoto of Magee Women's Hospital of UPMC in PittsburghPhoto of Magee Women's Hospital of UPMC in Pittsburgh

Summary

Magee Women's Hospital of UPMC is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Ovarian Cancer, Breast cancer, Cervical Adenocarcinoma and other specialties. Magee Women's Hospital of UPMC is involved with conducting 403 clinical trials across 569 conditions. There are 44 research doctors associated with this hospital, such as Adam Brufsky, MD, Melissa A. Burgess, Alexander B. Olawaiye, and Adam Olson.

Area of expertise

1Breast Cancer
Global Leader
Magee Women's Hospital of UPMC has run 92 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
Stage IV
ER positive
2Parotid Gland Cancer
Global Leader
Magee Women's Hospital of UPMC has run 69 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I

Top PIs

Clinical Trials running at Magee Women's Hospital of UPMC

Breast Cancer
Parotid Gland Cancer
Cancer
Prostate Cancer
Breast cancer
Lung Cancer
Ovarian Cancer
Pre-eclampsia
Endometrial Cancer
Testicular cancer
Image of trial facility.

Sacituzumab Govitecan

for Triple-Negative Breast Cancer

This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Image of trial facility.

Contrast-Enhanced Mammography

for Breast Abnormalities

One of the primary criticisms of mammography is that it leads to unneeded stress and anxiety from identification and biopsy of non-cancerous findings. Contrast-enhanced mammography (CEM) has the potential to significantly reduce biopsy rates for commonly seen benign breast lesions while preserving very high cancer detection. The investigators propose a prospective clinical study of patients with diagnostic mammograms rated as BIRADS 4A or 4B and scheduled for a biopsy, in which, prior to undergoing their scheduled biopsy, a CEM procedure is performed. The investigators will test the primary hypothesis that for soft tissue lesions (i.e. masses, asymmetries, architectural distortions) initially rated BI-RADS 4A/4B adding CEM will reduce, by at least 20%, the number of biopsy recommendations for actually benign cases and, at the same time, provide a negative predictive value (NPV) higher than 95%.
Recruiting3 awards Phase 43 criteria
Image of trial facility.

Giredestrant + Hormone Therapy

for Early-Stage Breast Cancer

This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Magee Women's Hospital of UPMC?
Where is Magee Women's Hospital of UPMC located?
Who should I call to ask about financial aid or insurance network?
What insurance does Magee Women's Hospital of UPMC accept?
What awards or recognition has Magee Women's Hospital of UPMC received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security